Jenny Robertson

Insider Reports History

Location
New York, NY
Signature
/s/ Youjin Choi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jenny Robertson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. Chief Legal Officer Common Stock 68,381 $633,891 $9.27 18 Nov 2025 Direct
Lexeo Therapeutics, Inc. Chief Legal Officer Stock Option (right to buy) 72,500 07 Jan 2025 Direct

Insider Reports Filed by Jenny Robertson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXEO Lexeo Therapeutics, Inc. 18 Nov 2025 1 -$5,089 4 Chief Legal Officer 20 Nov 2025, 17:18
LXEO Lexeo Therapeutics, Inc. 15 Oct 2025 3 -$31,530 4 Chief Legal Officer 17 Oct 2025, 19:28
LXEO Lexeo Therapeutics, Inc. 18 Aug 2025 1 -$2,530 4 Chief Legal Officer 20 Aug 2025, 17:03
LXEO Lexeo Therapeutics, Inc. 16 May 2025 1 -$1,445 4 Chief Legal Officer 20 May 2025, 17:00
LXEO Lexeo Therapeutics, Inc. 14 Mar 2025 1 +$14,929 4 Chief Legal Officer 09 Apr 2025, 17:46
LXEO Lexeo Therapeutics, Inc. 19 Feb 2025 1 -$9,272 4 Chief Legal Officer 21 Feb 2025, 17:08
LXEO Lexeo Therapeutics, Inc. 07 Jan 2025 2 $0 4 Chief Legal & Admin Officer 10 Jan 2025, 16:55
LXEO Lexeo Therapeutics, Inc. 05 Jan 2024 2 $0 4 Chief Legal and Admin Officer 09 Jan 2024, 18:50
LXEO Lexeo Therapeutics, Inc. 02 Nov 2023 0 $0 3 Chief Legal and Admin. Officer 02 Nov 2023, 21:41